Insider · CIK 0001755198

Boissel Stephane

Reports to the SEC for 1 company · RICHMOND, CA

sec.gov

Transactions

Companies

Filings

CIK

0001755198

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-07-03	SGMOQSANGAMO THERAPEUTICS, INC · Free Shares Call Options (obligation to sell to Issuer)E Expiration	EVP, Corp. Strategy	EExpiration	−1 sh	—	—	1
2020-06-04	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	EVP, Corp. Strategy	MExercise/Conversion	+14.9K sh	—	—	85,023
2020-06-04	SGMOQSANGAMO THERAPEUTICS, INCD Disposition to Issuer	EVP, Corp. Strategy	DDisposition to Issuer	−14.9K sh	$11.23	−$167K	70,116
2020-06-04	SGMOQSANGAMO THERAPEUTICS, INC · Free Shares Put Option (right to sell to Issuer)M Exercise/Conversion	EVP, Corp. Strategy	MExercise/Conversion	−1 sh	—	—	2
2020-05-09	SGMOQSANGAMO THERAPEUTICS, INC · Free Shares Call Options (obligation to sell to Issuer)E Expiration	EVP, Corp. Strategy	EExpiration	−1 sh	—	—	2
2020-02-25	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	EVP, Corp. Strategy	FTax Payment	−2,384 sh	$6.80	−$16.2K	15,116
2020-02-25	SGMOQSANGAMO THERAPEUTICS, INCA Award	EVP, Corp. Strategy	AAward	+55K sh	—	—	70,116
2020-02-25	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right-to-Buy)A Award	EVP, Corp. Strategy	AAward	+110K sh	—	—	110,000
2019-08-12	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	EVP, Corp. Strategy	MExercise/Conversion	+11.1K sh	—	—	28,637
2019-08-12	SGMOQSANGAMO THERAPEUTICS, INCD Disposition to Issuer	EVP, Corp. Strategy	DDisposition to Issuer	−11.1K sh	$11.23	−$125K	17,500
2019-08-12	SGMOQSANGAMO THERAPEUTICS, INC · Free Shares Put Option (right to sell to Issuer)M Exercise/Conversion	EVP, Corp. Strategy	MExercise/Conversion	−1 sh	—	—	3
2019-07-03	SGMOQSANGAMO THERAPEUTICS, INC · Free Shares Call Options (obligation to sell to Issuer)E Expiration	EVP, Corp. Strategy	EExpiration	−1 sh	—	—	3
2019-02-25	SGMOQSANGAMO THERAPEUTICS, INCA Award	EVP, Corp. Strategy	AAward	+17.5K sh	—	—	17,500
2019-02-25	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right-to-Buy)A Award	EVP, Corp. Strategy	AAward	+105K sh	—	—	105,000
2018-11-27	SGMOQSANGAMO THERAPEUTICS, INC · Free Shares Call Options (obligation to sell to Issuer)J Other	EVP, Corp. Strategy	JOther	−4 sh	—	—	4
2018-11-27	SGMOQSANGAMO THERAPEUTICS, INC · Free Shares Put Options (right to sell to Issuer)J Other	EVP, Corp. Strategy	JOther	+4 sh	—	—	4
2018-11-23	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	EVP, Corp. Strategy	AAward	+284K sh	—	—	283,523

Recent filings

Accepted (ET)
Jul 314
Boissel Stephane0001209191-20-044347
SEC(opens sec.gov)
Jun 54
Boissel Stephane0001209191-20-034882
SEC(opens sec.gov)
Feb 264
Boissel Stephane0001209191-20-013229
SEC(opens sec.gov)
Feb 125
Boissel Stephane0001209191-20-008969
SEC(opens sec.gov)
Aug 144
Boissel Stephane0001209191-19-045960
SEC(opens sec.gov)
Aug 144
Boissel Stephane0001209191-19-045963
SEC(opens sec.gov)
Feb 274
Boissel Stephane0001209191-19-014302
SEC(opens sec.gov)
Nov 264
Boissel Stephane0001209191-18-059976
SEC(opens sec.gov)

Companies

SANGAMO THERAPEUTICS, INCEVP, Corp. StrategySGMOQ

Address

C/O SANGAMO THERAPEUTICS, INC. POINT RICHMOND TECH CTR, 501 CANAL BLVD.

RICHMOND, CA, 94804